Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
BV100 (300 mg)
DRUG
2 trials
Sponsors
BioVersys AG
, BioVersys SAS
Conditions
Acinetobacter Baumannii-calcoaceticus Complex
Bacterial Infections
Colistin Resistanrt ABC
Hospital Acquired Bacterial Pneumonia (HABP)
Ventilator Associated Bacterial Pneumonia (VABP)
Phase 1
To Evaluate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of BV100
Completed
NCT05684718
BioVersys AG
Bacterial Infections
Start: 2023-02-01
End: 2023-10-31
Updated: 2023-11-21
Phase 3
Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Not yet recruiting
NCT07326540
BioVersys SAS
Acinetobacter Baumannii-calcoaceticus Complex, Colistin Resistanrt ABC, Hospital Acquired Bacterial Pneumonia (HABP) +1
Start: 2026-03-20
End: 2028-03-30
Target: 248
Updated: 2026-01-08